Searching. Please wait…
1582
37
171
29406
4423
2606
347
392
Abstract: Melphalan flufenamide (melflufen) is a first-in-class peptide?drug conjugate that takes advantage of increased aminopeptidase activity inside tumor cells to rapidly release alkylating agents therein. Melflufen in combination with dexamethasone has been evaluated in multiple clinical trials in patients with relapsed/refractory multiple myeloma (MM).
Fuente: Expert Rev Clin Pharmacol . 2022 Apr;15(4):371-382
Publisher: Taylor & Francis
Year of publication: 2022
No. of pages: 12
Publication type: Article
DOI: 10.1080/17512433.2022.2075847
ISSN: 1751-2433,1751-2441
Publication Url: https://doi.org/10.1080/17512433.2022.2075847
Google Scholar
Citations
Read publication
ENRIQUE MARIA OCIO SAN MIGUEL
NADEEM, OMAR
SCHJESVOLD, FREDRIK
GAY, FRANCESCA
TOUZEAU, CYRILLE
DIMOPOULOS, MELETIOS A.
RICHARDSON, PAUL G.
MATEOS, MARIA-VICTORIA
Back